Lv5
1470 积分 2021-12-12 加入
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
1小时前
待确认
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
7天前
已完结
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
14天前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
22天前
已完结
The present and future of bispecific antibodies for cancer therapy
22天前
已完结
Molecular mechanisms of T cell co-stimulation and co-inhibition
23天前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
24天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
2个月前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
3个月前
已完结
Abstract 5202: AMG 794, a Claudin 6-targeted half-life extended (HLE) bispecific T cell engager (BITE®) molecule for non-small cell lung cancer and epithelial ovarian cancer
3个月前
已关闭
皖公网安备34019202002308
